Health and Healthcare

Thursday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

PIPEX PHARMACEUTICAL [PPXP.OB] +21.70%
BIODELIVERY SCI INTL [BDSI] +21.37%
AURIGA LABORATORIES [ARGA.OB] +20.83%
BIONOVO INC [BNVI.OB] +10.73%
BIOSANTE PHARMA INC [BPA] +10.05%

Diagnostic Substances

ASPENBIO PHARMA INC [APNB.OB] +12.62%
LEXICON GENETICS I [LEXG] +11.05%
ICAGEN, INC. [ICGN] +7.31%
NYMOX PHARM CORP [NYMX] +6.67%
MONOGRAM BIOSCIENCES [MGRM] +5.67%

Drug Delivery

MATRIXX INITIATVS [MTXX] +11.96%
GENEREX BIOTECH CORP [GNBT] +7.95%
BENTLEY PHARMACEUTIC [BNT] +2.94%
INSITE VISION INC [ISV] +1.28%
NOVEN PHARMACEUTIC [NOVN] +1.24%

Drug Manufacturers

CORTEX PHARM INC [COR] +42.61%
EXEGENICS INC [EXEG.OB] +7.77%
ENDO PHARM HLDGS I [ENDP] +6.06%
UNIGENE LABS INC [UGNE.OB] +3.35%
ATHEROGENICS INC [AGIX] +3.14%

Medical Appliances & Equipment

MEDIS TECH LTD [MDTL] +12.86%
LANGER INC [GAIT] +11.00%
STEREOTAXIS, INC. [STXS] +10.15%
QMED INC [QMED] +9.72%
SYMMETRY MEDICAL INC [SMA] +5.29%

Medical Instruments & Supplies

IMMUNOCELLULAR THERA [IMUC.OB] +12.50%
MICROMED CARDIOVASCU [MMCV.OB] +9.38%
MINDRAY MEDICAL INTL [MR] +8.19%
ENDOLOGIX INC [ELGX] +6.99%
RETRACTABLE TECH INC [RVP] +4.50%

http://www.biohealthinvestor.com/

Medical Laboratories & Research

MEDASORB TECHNOLOGS [MSBT.OB] +28.57%
SPHERIX INC [SPEX] +4.37%
MEDTOX SCIENTFIC INC [MTOX] +3.58%
OSI PHARMACEUTIC [OSIP] +2.35%
ERESEARCHTECHNOLOG [ERES] +1.53%

Sponsored: Want to Retire Early? Here’s a Great First Step

Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.